This year’s government work report proposes to support the revitalization and development of traditional Chinese medicine and promote the comprehensive reform of traditional Chinese medicine. On March 7, Zhang Feng, member of the National Committee of the Chinese people’s Political Consultative Conference and Shenzhen Neptunus Bioengineering Co.Ltd(000078) president, said in an interview with the reporter of Securities Daily that he submitted two proposals this year, focusing on the construction of the whole industrial chain of traditional Chinese medicine industry and the development of classic prescriptions of traditional Chinese medicine.
Traditional Chinese medicine is the material basis for the inheritance and development of traditional Chinese medicine. With the continuous development of traditional Chinese medicine industry, there are some urgent problems to be solved, such as the increase of traditional Chinese medicine planting scale, but the lack of source supervision; The quality problems of traditional Chinese medicine are still prominent, and the construction of quality traceability system of traditional Chinese medicine is still lacking; The modernization level of traditional Chinese medicine production needs to be improved, and the modern traditional Chinese medicine industry chain urgently needs to be extended. In this context, Zhang Feng suggested to strengthen the construction of the whole industrial chain and promote the high-quality development of traditional Chinese medicine industry.
Referring to specific suggestions, Zhang Feng said that the whole process traceability system of traditional Chinese medicine is a basic project to ensure the quality of traditional Chinese medicine. It is suggested that functional departments such as the State Administration of traditional Chinese medicine, the food and drug administration, the Ministry of agriculture and rural areas and the Health Commission should organize and establish a special leading group to promote and improve the circulation traceability system of traditional Chinese medicine in China.
At the same time, Zhang Feng believes that the processing specifications of traditional Chinese medicine should be formulated and the catalogue of processed varieties should be expanded.
“At present, national laws and regulations clearly stipulate that only 68 varieties are allowed to be processed in the producing area. The actual situation is that many medicinal materials have been processed in the fresh producing area, which is beyond the scope of the specified variety catalogue.” Zhang Feng said that it is suggested that through further variety expansion research, the catalogue of processed varieties in origin should be formulated to ensure the internal quality of raw medicinal materials, shorten the length of industrial chain and reduce production costs.
In addition, Zhang Feng also suggested promoting the third-party quality inspection of traditional Chinese medicine, establishing a GMP system in line with the characteristics of traditional Chinese medicine, strengthening the development of traditional Chinese medicine health industry, and constantly extending the modern traditional Chinese medicine industry chain.
Zhang Feng also noted that since 2018, the state has not released the selection catalogue of classic famous parties. To this end, he suggested further strengthening the selection of classic famous prescriptions, following the fundamental principle of meeting people’s health needs and guided by clinical value, publishing more catalogs of classic famous prescriptions, promoting the simplified registration of classic famous prescriptions, accelerating the secondary development of ancient classic famous prescriptions, further stimulating the vitality of classic famous prescriptions and promoting the comprehensive upgrading of traditional Chinese medicine industry.
Zhang Feng said that China has a long history of traditional medicine resources, and the classic name is the most outstanding part of the great treasure house of Chinese medicine. Based on the current development situation of traditional Chinese medicine, how to follow the ancient ideas, improve the modern standards, strengthen the research and development of classic famous prescriptions and strengthen the protection of traditional famous prescriptions is of great significance for the inheritance, innovation and development of traditional Chinese medicine.
For accelerating the R & D and listing of classical famous prescriptions of traditional Chinese medicine, Zhang Feng suggested that the government establish a risk fund to support the R & D and innovation of classical famous prescriptions of traditional Chinese medicine, integrate relevant resources, jointly undertake or subsidize some classical famous prescriptions of traditional Chinese medicine projects with high technical risks and are expected to make major breakthroughs, so as to improve the commercialization process of classical famous prescriptions of traditional Chinese medicine.
